TGF-β1 Protein

TGF-β1 Protein

Introduction

TGF-β1 (Transforming Growth Factor Beta 1) is a multifunctional cytokine that plays critical roles in regulating inflammation, tissue repair, and neuroprotection in the central nervous system. As one of the most important anti-inflammatory cytokines, TGF-β1 exerts complex effects on neuronal survival, astrocyte function, microglial activation, and immune cell behavior. This page provides comprehensive information about TGF-β1 structure, signaling mechanisms, normal CNS functions, and its dual roles in neurodegenerative diseases.

--- [@krieglstein2012]

title: TGF-β1 Protein [@tesseur2006]
description: TGF-β1 Transforming Growth Factor Beta-1 - Anti-inflammatory cytokine in neuroprotection and neurodegeneration [@chen2020]

--- [@von2015]

<div class="infobox infobox-protein"> [@luo2017]

| | | [@wysscoray2003]
|---|---| [@tatenhorst2016]
| Protein Name | Transforming Growth Factor Beta-1 (TGF-β1) | [@qian2018]
| Gene | [TGFB1](/proteins/tgfb1-protein) | [@makwana2010]
| UniProt ID | [P01137](https://www.uniprot.org/uniprot/P01137) |
| PDB ID | 3KFD, 1TGF, 2PJY |
| Molecular Weight | 25 kDa (latent), 12.5 kDa (active) |
| Amino Acids | 390 (prepro), 112 (mature) |
| Structure | Cysteine knot growth factor fold |
| Chromosome | 19q13.2 |

</div>

Overview

TGF-β1 Protein

Introduction

TGF-β1 (Transforming Growth Factor Beta 1) is a multifunctional cytokine that plays critical roles in regulating inflammation, tissue repair, and neuroprotection in the central nervous system. As one of the most important anti-inflammatory cytokines, TGF-β1 exerts complex effects on neuronal survival, astrocyte function, microglial activation, and immune cell behavior. This page provides comprehensive information about TGF-β1 structure, signaling mechanisms, normal CNS functions, and its dual roles in neurodegenerative diseases.

--- [@krieglstein2012]

title: TGF-β1 Protein [@tesseur2006]
description: TGF-β1 Transforming Growth Factor Beta-1 - Anti-inflammatory cytokine in neuroprotection and neurodegeneration [@chen2020]

--- [@von2015]

<div class="infobox infobox-protein"> [@luo2017]

| | | [@wysscoray2003]
|---|---| [@tatenhorst2016]
| Protein Name | Transforming Growth Factor Beta-1 (TGF-β1) | [@qian2018]
| Gene | [TGFB1](/proteins/tgfb1-protein) | [@makwana2010]
| UniProt ID | [P01137](https://www.uniprot.org/uniprot/P01137) |
| PDB ID | 3KFD, 1TGF, 2PJY |
| Molecular Weight | 25 kDa (latent), 12.5 kDa (active) |
| Amino Acids | 390 (prepro), 112 (mature) |
| Structure | Cysteine knot growth factor fold |
| Chromosome | 19q13.2 |

</div>

Overview

TGF-β1 is a member of the TGF-β superfamily (which includes TGF-β1, TGF-β2, TGF-β3, bone morphogenetic proteins, and others). It is synthesized as a preproprotein that undergoes proteolytic processing to generate the mature active cytokine. TGF-β1 is secreted in a latent form (LAP - Latency-Associated Peptide) and must be activated to signal.

In the CNS, TGF-β1 is produced by [neurons](/entities/neurons), astrocytes, [microglia](/cell-types/microglia-neuroinflammation), and infiltrating immune cells. It regulates:

• Neuroinflammation (generally anti-inflammatory)
• Neuronal survival and [apoptosis](/entities/apoptosis)
• Astrocyte function and reactivity
• Extracellular matrix remodeling
• [Blood-brain barrier](/entities/blood-brain-barrier) integrity

Protein Structure

Primary Structure

TGF-β1 is synthesized as a 390-amino acid preproprotein:

• Signal peptide (1-20 aa): Secretion signal
• Latency-associated peptide (LAP) (21-259 aa): Forms inactive complex
• Mature peptide (280-390 aa): Biologically active cytokine

Processing

TGF-β1 undergoes complex post-translational processing:

Latent TGF-β1 Binding Protein (LTBP)

LTBP-1 binds the latent TGF-β1 complex:

• Targets TGF-β1 to extracellular matrix
• Helps maintain latency
• Facilitates activation

Tertiary Structure

The mature TGF-β1 adopts a cysteine knot fold:

• 7 conserved cysteines forming 3 disulfide bonds
• Cysteine knot stabilizes structure
• Dimerization creates symmetrical structure
• Receptor binding sites on opposite faces

Signaling Mechanisms

TGF-β Receptor Complex

TGF-β signals through receptor serine/threonine kinases:

Type I Receptors (ALK5/TβRI):

• Essential for Smad signaling
• Kinase activity required

• Binds ligand with high affinity
• Constitutively active kinase
• Transphosphorylates Type I

• Co-receptor, enhances binding
• Present on most cell types

Smad-Dependent Signaling

R-Smads:

• Smad2, Smad3: TGF-β/Activin pathway
• Smad1, Smad5, Smad8: BMP pathway

• Smad4: Partner for all R-Smads

Smad-Independent Pathways

TGF-β also activates:

• MAPK pathways: ERK, JNK, p38
• PI3K/AKT: Cell survival
• Rho GTPases: Cytoskeletal dynamics
• TAK1: [NF-κB](/entities/nf-kb) activation

Transcriptional Regulation

Smad complexes regulate gene expression:

• Co-activators: p300/CBP, histone acetyltransferases
• Co-repressors: Ski, SnoN, TGIF
• DNA binding: Smad binding elements (SBE)

Normal Function in the CNS

Neuronal Functions

• Neuroprotection: Protects neurons from various insults
• Axon guidance: Regulates growth cone behavior
• Synaptic plasticity: Modulates neurotransmitter release
• Neurogenesis: Influences neural stem cell fate

Glial Functions

[Astrocytes](/entities/astrocytes):

• Promotes astrocyte differentiation
• Regulates [GFAP](/entities/gfap) expression
• Controls astrocyte reactivity (generally suppressive)
• Enhances [Aβ](/proteins/amyloid-beta) clearance via astrocyte uptake

• Generally suppresses microglial activation
• Shifts toward anti-inflammatory (M2) phenotype
• Reduces cytokine production

• Promotes oligodendrocyte precursor survival
• Regulates myelination
• Affects remyelination

Immune Regulation

• Anti-inflammatory: Inhibits T cell proliferation
• Th17 regulation: Controls Th17 differentiation
• B cells: Modulates antibody production
• Monocytes/macrophages: Shifts toward M2 phenotype

Tissue Homeostasis

• Blood-brain barrier: Maintains BBB integrity
• Extracellular matrix: Regulates ECM production
• Wound healing: Essential for tissue repair

Role in Disease

Alzheimer's Disease

TGF-β1 has complex, often beneficial roles in AD:

Expression patterns:

• Elevated in AD brain and CSF
• Increased around amyloid plaques
• Genetic variants affect AD risk

• Aβ clearance: Enhances astrocyte and microglia-mediated clearance
• Synaptic protection: Protects against Aβ toxicity
• Anti-inflammatory: Suppresses harmful neuroinflammation
• Neuronal survival: Promotes neuron viability

• Plaque fibrosis: May contribute to plaque compaction
• Vascular dysfunction: Can affect cerebral vasculature

• TGF-β1 signaling enhancers being investigated
• Gene therapy approaches tested in models
• Caution needed: too much may be harmful

Parkinson's Disease

In PD, TGF-β1 has neuroprotective potential:

Expression patterns:

• Decreased in substantia nigra of PD patients
• Elevated in CSF in some studies

• Dopaminergic neuron survival: Promotes SNc neuron viability
• Microglial modulation: Reduces harmful inflammation
• [α-Synuclein](/proteins/alpha-synuclein): May affect aggregation
• Mitochondrial protection: Improves mitochondrial function

• TGF-β1 delivery protects dopaminergic neurons in models
• Combinatorial approaches with neurotrophic factors
• AAV-mediated expression being explored

Amyotrophic Lateral Sclerosis

TGF-β1 plays complex roles in ALS:

Expression patterns:

• Elevated in spinal cord of ALS patients
• Increased in serum
• Correlates with disease progression

• Motor neuron protection: Can protect motor neurons
• Glial modulation: Affects astrocyte and microglia reactivity
• Immune regulation: Shifts toward anti-inflammatory
• Controversy: Timing and context determine effects

• TGF-β1 delivery approaches in clinical trials
• Antisense oligonucleotides targeting TGF-β
• Need to balance neuroprotection vs. fibrosis

Multiple Sclerosis

In MS, TGF-β1 has regulatory roles:

Expression patterns:

• Decreased in MS lesions
• Low in serum during active disease

• Autoimmunity suppression: Inhibits pathogenic T cells
• Remyelination: Promotes oligodendrocyte function
• BBB protection: Maintains barrier integrity

• TGF-β1 as therapeutic agent investigated
• Gene therapy approaches
• Caution: can promote fibrosis

Other Neurodegenerative Conditions

• Huntington's disease: Neuroprotective in models
• Frontotemporal dementia: Dysregulated in some cases
• Stroke: Protective in ischemia models
• Traumatic brain injury: Promotes recovery

Therapeutic Targeting

Approaches to Enhance TGF-β1 Signaling

| Agent | Mechanism | Status |
|-------|-----------|--------|
| Recombinant TGF-β1 | Direct ligand | Preclinical |
| AAV-TGFβ1 | Gene therapy | Preclinical |
| Smad7 siRNA | Reduce inhibition | Research |
| Integrin agonists | Enhance activation | Research |

Approaches to Block TGF-β1

Used in conditions of excessive fibrosis:

| Agent | Mechanism | Status |
|-------|-----------|--------|
| Fresolimumab | Anti-TGF-β antibody | Clinical trials |
| LY2109761 | TβRI/II inhibitor | Cancer trials |
| SMAD7 gene therapy | Decoy | Research |

Challenges

• BBB penetration: Most biologics cannot reach CNS
• Pleiotropy: Systemic effects may be harmful
• Dose timing: Critical for outcome
• Fibrosis risk: Excess TGF-β1 causes tissue scarring

Genetic Variation

TGFB1 polymorphisms affect disease risk:

• -509 C/T (rs1800469): T allele associated with higher TGF-β1, may protect neurons
• +10 T/C (rs1982073): Coding variant affecting protein
• -800 G/A (rs1800628): Functional promoter variant
• Disease associations: Variants linked to AD, PD risk

Biomarker Potential

TGF-β1 as a biomarker:

• CSF levels: Altered in AD, PD, ALS, MS
• Blood levels: Generally not disease-specific
• Prognostic value: May predict progression
• Therapeutic monitoring: Could track treatment response

Research Tools

• Recombinant proteins: Human, murine, rat TGF-β1
• Transgenic mice: Tgfβ1 knockout, conditional mutants
• ELISA kits: Sensitive quantification
• Reporter constructs: Smad-responsive elements
• AAV vectors: CNS-targeted gene delivery

Summary

TGF-β1 is a critical anti-inflammatory cytokine with complex roles in neurodegeneration. It generally promotes neuronal survival, modulates glial function, and suppresses harmful neuroinflammation, making it an attractive therapeutic target. However, its pleiotropic nature and potential for fibrosis require careful approach. Enhancing TGF-β1 signaling in the CNS represents a promising strategy for AD, PD, and ALS, though significant challenges remain in achieving targeted delivery and appropriate dosing.

Background

The study of Tgf Β1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• [TGFB1 Gene](/genes/tgfb1)
• [TGFB2 Gene](/genes/tgfb2)
• [TGFB3 Gene](/genes/tgfb3)
• [Proteins Index](/proteins)
• [Genes Index](/genes)
• [Neuroinflammation Pathway](/mechanisms/neuroinflammation)
• [Cytokine Signaling in Neurodegeneration](/mechanisms/cytokine-signaling-neurodegeneration)
• [Smad Signaling Pathway](/mechanisms/smad-signaling-pathway)
• [Alzheimer's Disease Mechanisms](/diseases/alzheimers-disease)
• [Parkinson's Disease Mechanisms](/diseases/parkinsons-disease)
• [ALS Mechanisms](/diseases/amyotrophic-lateral-sclerosis)
• [Microglia in Neurodegeneration](/cell-types/microglia)
• [Astrocytes in Neurodegeneration](/cell-types/astrocytes)

External Links

• [UniProt: P01137](https://www.uniprot.org/uniprot/P01137)
• [PDB: 3KFD](https://www.ebi.ac.uk/pdbe/entry/pdb/3kfd)
• [GeneCards: TGFB1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=TGFB1)
• [NCBI Gene: 7048](https://www.ncbi.nlm.nih.gov/gene/7048)
• [OMIM: 191180](https://www.omim.org/entry/191180)

References